+49 1521 6613828
| caslinkllc@gmail.com |
| Business Type | Exporter, Supplier, Retailer, Trader, Distributor |
| Packaging Type | Boxes |
| Brand Name | Ponatinib |
| Dosage Form | Tablets |
| Click to view more | |
Product Details
Ponatinib is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia ( CML) that is resistant or intolerant to prior TKI therapy or philadelphia chromose positive acute lymbhoblastic leukemia (PH+ ALL) that is resistant or intolerant to prior TKI therapy
Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.